Combinatorial patterns of somatic gene mutations in cancer
Abstract
Cancer is a complex process in which the abnormalities of many genes appear to be involved. The combinatorial patterns of gene mutations may reveal the functional relations between genes and pathways in tumorigenesis as well as identify targets for treatment. We examined the patterns of somatic mutations of cancers from Catalog of Somatic Mutations in Cancer (COSMIC), a large‐scale database curated by the Wellcome Trust Sanger Institute. The frequently mutated genes are well‐known oncogenes and tumor suppressors that are involved in generic processes of cell‐cycle control, signal transduction, and stress responses. These “signatures” of gene mutations are heterogeneous when the cancers from different tissues are compared. Mutations in genes functioning in different pathways can occur in the same cancer ( i.e. , co‐occur), whereas those in genes functioning in the same pathway are rarely mutated in the same sample. This observation supports the view of tumorigenesis as derived from a process like Darwinian evolution. However, certain combinatorial mutational patterns violate these simple rules and demonstrate tissue‐specific variations. For instance, mutations of genes in the Ras and Wnt pathways tend to co‐occur in the large intestine but are mutually exclusive in cancers of the pancreas. The relationships between mutations in different samples of a cancer can also reveal the temporal orders of mutational events. In addition, the observed mutational patterns suggest candidates of new cosequencing targets that can either reveal novel patterns or validate the predictions deduced from existing patterns. These combinatorial mutational patterns provide guiding information for the ongoing cancer genome projects.—Yeang, C‐H., McCormick, F., Levine, A. Combinatorial patterns of somatic gene mutations in cancer. FASEB J. 22, 2605–2622 (2008)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several KRAS alleles had reduced comutation with NRAS and BRAF, and increased comutation with APC and PIK3CA.
“Several KRAS alleles had reduced comutation with NRAS and BRAF, and increased comutation with APC and PIK3CA”
From The origins and genetic interactions of KRAS mutations are allele- and tissue-specific (2021) · cites this paper as [48]
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works
Self-citationGenetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704 · see citing works
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · see citing works
Self-citationBarbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885 · see citing works
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · see citing works
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1609 · Cited by 3,313 · see citing works
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104 · see citing works
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,021 · see citing works
Hirsch, F. R., Varella‐Garcia, M., Bunn, P. A., Maria, M. V. D., Veve, R., Bremnes, R. M., Barón, A. E., Zeng, C., & Franklin, W. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.069 · Cited by 1,476 · see citing works
Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
Kölch, W. (2000) · Biochemical Journal · doi:10.1042/bj3510289 · Cited by 1,443 · see citing works
Receptor Protein-Tyrosine Kinases and Their Signal Transduction Pathways
van der Geer, P., Hunter, T., & Lindberg, R. A. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.001343 · Cited by 1,345 · see citing works
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341 · see citing works
Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P. F., El‐Gamil, M., Albert, I., Porfiri, E., & Polakis, P. G. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223 · see citing works
Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.
Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Horiike, S., Kashima, K., Sonoda, Y., Fujimoto, T., & Misawa, S. (1996) · PubMed · Cited by 1,162 · see citing works
TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4
Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C., Miyazono, K., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5353 · Cited by 1,071 · see citing works
Rodriguez‐Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M., Pappin, D., Das, P., Waterfield, M. D., Ridley, A. J., & Downward, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80226-3 · Cited by 1,063 · see citing works
Gastrointestinal stromal tumour
Rubin, B. P., Heinrich, M. C., & Corless, C. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60780-6 · Cited by 1,037 · see citing works
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899 · see citing works
Ras proteins: different signals from different locations
Hancock, J. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1105 · Cited by 856 · see citing works
Genetic instability and darwinian selection in tumours
Cahill, D. P., Kinzler, K. W., Vogelstein, B., & Christoph Lengauer, C. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01661-x · Cited by 747 · see citing works
The Raf/MEK/ERK pathway: new concepts of activation
Peyssonnaux, C., & Eychène, A. (2001) · Biology of the Cell · doi:10.1016/s0248-4900(01)01125-x · Cited by 734 · see citing works
Functional genomic hypothesis generation and experimentation by a robot scientist
King, R. D., Whelan, K. E., Jones, F. M., Reiser, P. G. K., Bryant, C. H., Muggleton, S. H., Kell, D. B., & Oliver, S. G. (2004) · Nature · doi:10.1038/nature02236 · Cited by 662 · see citing works
Feng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4149 · Cited by 633 · see citing works
Self-citationA receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations
Matthews, W., Jordan, C. T., Wiegand, G. W., Pardoll, D., & Lemischka, I. R. (1991) · Cell · doi:10.1016/0092-8674(91)90010-v · Cited by 593 · see citing works
Evidence that SNF2/SWI2 and SNF5 activate transcription in yeast by altering chromatin structure.Preprint
Hirschhorn, J. N., Brown, S. A., Clark, C. D., & Winston, F. (1992) · Genes & Development · doi:10.1101/gad.6.12a.2288 · Cited by 528 · see citing works
The Wnt signaling pathway and its role in tumor development
Lustig, B., & Behrens, J. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0431-0 · Cited by 521 · see citing works
Lyman, S. D., James, L., Bos, T. V., de Vries, P., Brasel, K., Gliniak, B., Hollingsworth, L. T., Picha, K. S., McKenna, H. J., Splett, R. R., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90325-k · Cited by 521 · see citing works
Abraham, S. C., Klimstra, D. S., Wilentz, R. E., Yeo, C. J., Conlon, K. C., Brennan, M. F., Cameron, J. L., Wu, T., & Hruban, R. H. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62563-1 · Cited by 487 · see citing works
Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexesPreprint
Liu, F., Pouponnot, C., & Massagué, J. (1997) · Genes & Development · doi:10.1101/gad.11.23.3157 · Cited by 445 · see citing works
Evolution of neoplastic cell lineages in Barrett oesophagus
Barrett, M. T., Sanchez, C. A., Prevo, L. J., Wong, D. J., Galipeau, P. C., Paulson, T. G., Rabinovitch, P. S., & Reid, B. J. (1999) · Nature Genetics · doi:10.1038/8816 · Cited by 440 · see citing works
Xiang, Y., Zheng, Q., Jia, B., Huang, G., Xie, C., Pan, J., & Wang, J. (2006) · Cell Biology International · doi:10.1016/j.cellbi.2006.11.012 · Cited by 429 · see citing works
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase
Chan, R. J., & Feng, G. (2006) · Blood · doi:10.1182/blood-2006-07-028829 · Cited by 378 · see citing works
C/EBPα Arrests Cell Proliferation through Direct Inhibition of Cdk2 and Cdk4
Wang, H., Iakova, P. A., Wilde, M., Welm, A. L., Goode, T., Roesler, W. J., & Timchenko, N. A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00366-5 · Cited by 354 · see citing works
Forbes, S. A., Clements, J., Dawson, E., Bamford, S., Webb, T., Doǧan, A., Flanagan, A. M., Teague, J. W., Wooster, R., Futreal, P. A., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602928 · Cited by 327 · see citing works
Coordination and communication between the p53 and IGF-1–AKT–TOR signal transduction pathways
Levine, A. J., Feng, Z., Mak, T. W., You, H., & Jin, S. (2006) · Genes & Development · doi:10.1101/gad.1363206 · Cited by 321 · see citing works
Self-citationJi, H., Zhao, X., Yuza, Y., Shimamura, T., Li, D., Protopopov, A. I., Jung, B. L., McNamara, K. L., Xia, H., Glatt, K. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510284103 · Cited by 256 · see citing works
Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
Tsao, H., Zhang, X., Fowlkes, K., & Haluska, F. G. (2000) · PubMed · Cited by 238 · see citing works
Hahn, H., Christiansen, J. H., Wicking, C., Zaphiropoulos, P. G., Chidambaram, A., Gerrard, B., Vořechovský, I., Bale, A. E., Toftgård, R., Dean, M. C., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12125 · Cited by 218 · see citing works
Serine/threonine phosphorylation in cytokine signal transduction
McCubrey, J. A., May, W. S., Duronio, V., & Mufson, A. (2000) · Leukemia · doi:10.1038/sj.leu.2401657 · Cited by 207 · see citing works
Bruening, W., Bardeesy, N. M., Silverman, B. L., Cohn, R. A., Machin, G. A., Aronson, A. J., Housman, D. E., & Pelletier, J. (1992) · Nature Genetics · doi:10.1038/ng0592-144 · Cited by 187 · see citing works
Sonobe, M., Manabe, T., Wada, H., & Tanaka, F. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602707 · Cited by 162 · see citing works
Hitting their targets: an emerging picture of E2F and cell cycle control
Blais, A., & Dynlacht, B. D. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.07.003 · Cited by 131 · see citing works
Christiansen, D. H., Andersen, M. K., Desta, F. Z., & Pedersen-Bjergaard, J. (2005) · Leukemia · doi:10.1038/sj.leu.2404009 · Cited by 121 · see citing works
Toyooka, M., Konishi, M., Kikuchi‐Yanoshita, R., Iwama∥, T., & Miyaki, M. (1995) · PubMed · Cited by 93 · see citing works
Validation and refinement of gene-regulatory pathways on a network of physical interactions
Yeang, C., Mak, H. C., McCuine, S., Workman, C. T., Jaakkola, T., & Ideker, T. E. (2005) · Genome biology · doi:10.1186/gb-2005-6-7-r62 · Cited by 83 · see citing works
Self-citationA functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice
To, M. D., Pérez‐Losada, J., Mao, J., Hsu, J., Jacks, T., & Balmain, A. (2006) · Nature Genetics · doi:10.1038/ng1836 · Cited by 69 · see citing works
Peng, B., Fleming, J. B., Breslin, T. M., Grau, A. M., Fojioka, S., Abbruzzese, J. L., Evans, D. B., Ayers, D., Wathen, K., Wu, T., et al. (2002) · PubMed · Cited by 66 · see citing works
The c-K-ras gene and human cancer (review).
Kahn, S., Yamamoto, F., Almoguera, C., Winter, E., Forrester, K., Jordano, J., & Perucho, M. (1987) · PubMed · Cited by 55 · see citing works
Ciesielski, M. J., & Fenstermaker, R. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203409 · Cited by 40 · see citing works
Wooster, R. F. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80006-5 · Cited by 23 · see citing works
FLT3 Mutations in Acute Myeloid Leukemia
Kiyoi, H., & Naoe, T. (2006) · Humana Press eBooks · doi:10.1385/1-59745-017-0:189 · Cited by 22 · see citing works
Establishment and characterization of four human pancreatic carcinoma cell lines
Ku, J., Yoon, K., Kim, W. H., Jang, J., Suh, K., Kim, S., Park, Y.-H., & Park, J. (2002) · Cell and Tissue Research · doi:10.1007/s00441-001-0510-y · Cited by 20 · see citing works
Inhibition of Ras oncogenic activity by Ras protooncogenes
Diaz, R., Lue, J., Mathews, J. A., Yoon, A., Ahn, D. H., García‐España, A., Leonardi, P., Vargas, M. P., & Pellicer, À. (2004) · International Journal of Cancer · doi:10.1002/ijc.20563 · Cited by 18 · see citing works
[FLT3 Mutations in Acute Myeloid Leukemia].
Shoji, T., Kida, Y., Yamashita, K., & Ichiyama, S. (2017) · PubMed · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · see citing works
Maftools: efficient and comprehensive analysis of somatic variants in cancerPreprint
Mayakonda, A., Lin, D., Assenov, Y., Plass, C., & Koeffler, H. P. (2018) · Genome Research · doi:10.1101/gr.239244.118 · Cited by 4,914 · see citing works
Leiserson, M. D. M., Vandin, F., Wu, H.-T., Dobson, J. R., Eldridge, J. V., Thomas, J. L., Papoutsaki, A., Kim, Y., Niu, B., McLellan, M. D., et al. (2014) · Nature Genetics · doi:10.1038/ng.3168 · Cited by 900 · see citing works
Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
MacConaill, L. E., Campbell, C. D., Kehoe, S. M., Bass, A. J., Hatton, C., Niu, L., Davis, M., Yao, K., Hanna, M., Mondal, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007887 · Cited by 434 · see citing works
De Novo Discovery of Mutated Driver Pathways in Cancer
Vandin, F., Upfal, E., & Raphael, B. J. (2011) · Lecture notes in computer science · doi:10.1007/978-3-642-20036-6_44 · Cited by 434 · see citing works
Cheon, D., & Oršulić, S. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.154244 · Cited by 397 · see citing works
Driver and Passenger Mutations in Cancer
Pon, J. R., & Marra, M. A. (2014) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040312 · Cited by 356 · see citing works
Simultaneous Identification of Multiple Driver Pathways in Cancer
Leiserson, M. D. M., Blokh, D., Sharan, R., & Raphael, B. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003054 · Cited by 236 · see citing works
Methods and Applications of CRISPR-Mediated Base Editing in Eukaryotic Genomes
Hess, G. T., Tycko, J., Yao, D., & Bassik, M. C. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.029 · Cited by 234 · see citing works
Raphael, B. J., Dobson, J. R., Oesper, L., & Vandin, F. (2014) · Genome Medicine · doi:10.1186/gm524 · Cited by 218 · see citing works
Kennedy, A. L., Morton, J. P., Manoharan, I., Nelson, D. M., Jamieson, N. B., Pawlikowski, J. S., McBryan, T., Doyle, B., McKay, C., Oien, K. A., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.020 · Cited by 213 · see citing works
Becht, É., Giraldo, N. A., Germain, C., de Reyniès, A., Laurent‐Puig, P., Zucman‐Rossi, J., Dieu‐Nosjean, M., Sautès‐Fridman, C., & Fridman, W. H. (2016) · Advances in immunology · doi:10.1016/bs.ai.2015.12.002 · Cited by 213 · see citing works
CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer
Leiserson, M. D. M., Wu, H.-T., Vandin, F., & Raphael, B. J. (2015) · Genome biology · doi:10.1186/s13059-015-0700-7 · Cited by 202 · see citing works
The origins and genetic interactions of KRAS mutations are allele- and tissue-specific
Cook, J. H., Melloni, G. E. M., Gulhan, D. C., Park, P. J., & Haigis, K. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22125-z · Cited by 208 · see citing works
Expanding the computational toolbox for mining cancer genomes
Ding, L., Wendl, M. C., McMichael, J. F., & Raphael, B. J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3767 · Cited by 184 · see citing works
FOXM1 (Forkhead box M1) in Tumorigenesis
Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 183 · see citing works
The Transcription Factor FOXM1 (Forkhead box M1)
Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 174 · see citing works
Canisius, S., Martens, J. W. M., & Wessels, L. F. A. (2016) · Genome biology · doi:10.1186/s13059-016-1114-x · Cited by 170 · see citing works
Babur, Ö., Gönen, M., Aksoy, B. A., Schultz, N. D., Ciriello, G., Sander, C., & Demir, E. (2015) · Genome biology · doi:10.1186/s13059-015-0612-6 · Cited by 161 · see citing works
Learning the pattern of epistasis linking genotype and phenotype in a protein
Poelwijk, F. J., Socolich, M., & Ranganathan, R. (2019) · Nature Communications · doi:10.1038/s41467-019-12130-8 · Cited by 165 · see citing works
Masica, D. L., & Karchin, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0180 · Cited by 159 · see citing works
Efficient methods for identifying mutated driver pathways in cancer
Zhao, J., Zhang, S., Wu, L., & Zhang, X.-S. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts564 · Cited by 155 · see citing works
Krumbach, R., Schüler, J. B., Hofmann, M., Giesemann, T., Fiebig, H., & Beckers, T. L. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.12.019 · Cited by 141 · see citing works
Miller, C. A., Settle, S. H., Sulman, E. P., Aldape, K., & Milosavljevic, A. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-34 · Cited by 126 · see citing works
Mallette, F. A., & Richard, S. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.033 · Cited by 119 · see citing works
Jia, P., & Zhao, Z. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003460 · Cited by 114 · see citing works
Dietary Supplements and Cancer Prevention: Balancing Potential Benefits Against Proven Harms
Martı́nez, M. E., Jacobs, E. T., Baron, J. A., Marshall, J. R., & Byers, T. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs195 · Cited by 112 · see citing works
NetSig: network-based discovery from cancer genomes
Horn, H., Lawrence, M. S., Chouinard, C. R., Shrestha, Y., Hu, J. X., Worstell, E., Shea, E., Ilic, N., Kim, E., Kamburov, A., et al. (2018) · Nature Methods · doi:10.1038/nmeth.4514 · Cited by 105 · see citing works
Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF
Cisowski, J., Sayin, V. I., Liu, M., Karlsson, C., & Bergo, M. O. (2016) · Oncogene · doi:10.1038/onc.2015.186 · Cited by 104 · see citing works
Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity
Tan, H., Bao, J., & Zhou, X. (2015) · Scientific Reports · doi:10.1038/srep12566 · Cited by 102 · see citing works
Unraveling the Genetics of Cancer: Genome Sequencing and Beyond
Wong, K. M., Hudson, T. J., & McPherson, J. D. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082509-141532 · Cited by 96 · see citing works
Rémy, É., Rebouissou, S., Chaouiya, C., Zinovyev, A. Y., Radvanyi, F., & Calzone, L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0602 · Cited by 97 · see citing works
Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis
Wilson, T. M., Maric, I., Simakova, O., Bai, Y., Chan, E. C., Olivares, N., Carter, M., Maric, D., Robyn, J. A., & Metcalfe, D. D. (2010) · Haematologica · doi:10.3324/haematol.2010.031690 · Cited by 94 · see citing works
Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression
Patel, R., Gao, M., Ahmad, I., Fleming, J., Singh, L. B., Singh, T., McKie, A. B., Seywright, M. M., Barnetson, R. J., Edwards, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63672 · Cited by 92 · see citing works
Discovery of co-occurring driver pathways in cancer
Zhang, J., Wu, L., Zhang, X., & Zhang, S. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-271 · Cited by 90 · see citing works
Algorithmic methods to infer the evolutionary trajectories in cancer progression
Caravagna, G., Graudenzi, A., Ramazzotti, D., Pamplona, R. S., Sano, L. D., Mauri, G., Moreno, V. R., Antoniotti, M., & Mishra, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520213113 · Cited by 87 · see citing works
Prospective Enterprise-Level Molecular Genotyping of a Cohort of Cancer Patients
MacConaill, L. E., Garcia, E., Shivdasani, P., Ducar, M. D., Adusumilli, R., Breneiser, M., Byrne, M. N., Chung, L. P., Conneely, J., Crosby, L., et al. (2014) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.06.004 · Cited by 87 · see citing works
Computational approaches for the identification of cancer genes and pathways
Dimitrakopoulos, C. M., & Beerenwinkel, N. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1364 · Cited by 85 · see citing works
Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer
Sechi, S., Frappaolo, A., Karimpour-Ghahnavieh, A., Piergentili, R., & Giansanti, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030933 · Cited by 84 · see citing works
Modeling Mutual Exclusivity of Cancer Mutations
Szczurek, E., & Beerenwinkel, N. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003503 · Cited by 82 · see citing works
GO-function: deriving biologically relevant functions from statistically significant functions
Wang, J., Zhou, X., Zhu, J., Gu, Y., Zhao, W., Zou, J., & Guo, Z. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr041 · Cited by 81 · see citing works
Myoepithelial Cell Differentiation Markers in Ductal Carcinoma in Situ Progression
Russell, T. D., Jindal, S., Agunbiade, S., Gao, D., Troxell, M. L., Borges, V. F., & Schedin, P. S. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.07.004 · Cited by 80 · see citing works
Modeling Mutual Exclusivity of Cancer Mutations
Szczurek, E., & Beerenwinkel, N. (2014) · Lecture notes in computer science · doi:10.1007/978-3-319-05269-4_24 · Cited by 75 · see citing works
Discovery of cancer common and specific driver gene sets
Zhang, J., & Zhang, S. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx089 · Cited by 74 · see citing works
Cornen, S., Guillé, A., Adélaı̈de, J., Addou-Klouche, L., Finetti, P., Saade, M.-R., Manai, M., Carbuccia, N., Bekhouche, I., Letessier, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0081843 · Cited by 69 · see citing works
Deng, Y., Luo, S., Deng, C., Luo, T., Yin, W., Zhang, H., Zhang, Y., Zhang, X., Lan, Y., Ping, Y., et al. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx109 · Cited by 61 · see citing works
Using single cell sequencing data to model the evolutionary history of a tumor
Kim, K. I., & Simon, R. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-27 · Cited by 62 · see citing works
Idikio, H. (2011) · Journal of Cancer · doi:10.7150/jca.2.107 · Cited by 63 · see citing works
TiMEx: a waiting time model for mutually exclusive cancer alterations
Constantinescu, S., Szczurek, E., Mohammadi, P., Rahnenführer, J., & Beerenwinkel, N. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv400 · Cited by 63 · see citing works
Nout, R. A., Bosse, T., Creutzberg, C. L., Jurgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen‐Banasik, E. M., van Eijk, R., ter Haar, N. T., & Smit, V. T. H. B. M. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.05.012 · Cited by 61 · see citing works
An analysis of substitution, deletion and insertion mutations in cancer genes
Iengar, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks290 · Cited by 62 · see citing works
The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms
Zhang, J., & Zhang, S. (2016) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2016.2640963 · Cited by 60 · see citing works
The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3
Sechi, S., Frappaolo, A., Belloni, G., Colotti, G., & Giansanti, M. G. (2015) · Oncotarget · doi:10.18632/oncotarget.3051 · Cited by 59 · see citing works
A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53
Kim, J., Roh, M., Doubinskaia, I., Algarroba, G. N., Eltoum, I.-E. A., & Abdulkadir, S. A. (2011) · Oncogene · doi:10.1038/onc.2011.236 · Cited by 57 · see citing works
A weighted exact test for mutually exclusive mutations in cancer
Leiserson, M. D., Reyna, M. A., & Raphael, B. J. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw462 · Cited by 56 · see citing works
Ishikawa, Y., Kiyoi, H., Tsujimura, A., Miyawaki, S., Miyazaki, Y., Kuriyama, K., Tomonaga, M., & Naoe, T. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01261.x · Cited by 51 · see citing works
Extracting consistent knowledge from highly inconsistent cancer gene data sources
Gong, X., Wu, R., Zhang, Y., Zhao, W., Cheng, L., Gu, Y., Zhang, L., Wang, J., Zhu, J., & Guo, Z. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-76 · Cited by 50 · see citing works
Fast randomization of large genomic datasets while preserving alteration counts
Gobbi, A., Iorio, F., Dawson, K. J., Wedge, D. C., Tamborero, D., Alexandrov, L. B., López-Bigas, N., Garnett, M. J., Jurman, G., & Sáez-Rodríguez, J. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu474 · Cited by 43 · see citing works
Modelling cancer progression using Mutual Hazard Networks
Schill, R., Solbrig, S., Tilo Wettig, B., & Spang, R. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz513 · Cited by 43 · see citing works
What makes oncogenes mutually exclusive?
Cisowski, J., & Bergö, M. O. (2016) · Small GTPases · doi:10.1080/21541248.2016.1212689 · Cited by 43 · see citing works
Datta, S., Ghosh, A., Dasgupta, D., Ghosh, A., Roychoudhury, S., Roy, G., Das, S., Das, K., Gupta, S. C., Basu, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110012 · Cited by 37 · see citing works
Cooperation between Noncanonical Ras Network Mutations
Stites, E. C., Trampont, P. C., Haney, L. B., Walk, S. F., & Ravichandran, K. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.035 · Cited by 35 · see citing works
Genetic variations as cancer prognostic markers: review and update
Savas, S., & Liu, G. (2009) · Human Mutation · doi:10.1002/humu.21078 · Cited by 35 · see citing works
Wang, W., Rayburn, E. R., Velu, S. E., Chen, D., Nadkarni, D. H., Srinivasan, M., Chen, D., & Zhang, R. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0638-0 · Cited by 35 · see citing works
Cooperative genomic alteration network reveals molecular classification across 12 major cancer types
Zhang, H., Deng, Y., Zhang, Y., Ping, Y., Zhao, H., Pang, L., Zhang, X., Wang, L., Xu, C., Xiao, Y., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1087 · Cited by 33 · see citing works
AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells
Coant, N., Garcı́a-Barros, M., Zhang, Q., Obeid, L. M., & Hannun, Y. A. (2018) · Oncogene · doi:10.1038/s41388-018-0236-x · Cited by 33 · see citing works
MEXCOwalk: mutual exclusion and coverage based random walk to identify cancer modules
Ahmed, R., Baali, I., Erten, C., Hoxha, E., & Kazan, H. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz655 · Cited by 33 · see citing works
Iorio, F., García‐Alonso, L., Brammeld, J. S., Martincorena, I., Willé, D. R., McDermott, U., & Sáez-Rodríguez, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25076-6 · Cited by 32 · see citing works
Simultaneous Inference of Cancer Pathways and Tumor Progression from Cross-Sectional Mutation Data
Raphael, B. J., & Vandin, F. (2015) · Journal of Computational Biology · doi:10.1089/cmb.2014.0161 · Cited by 32 · see citing works
Liu, C., Zhang, Y., Deng, Q., Li, Y., Huang, T., Zhou, S., & Cai, Y. (2017) · BioMed Research International · doi:10.1155/2017/3859582 · Cited by 32 · see citing works
Cancer classification and pathway discovery using non-negative matrix factorization
Zeng, Z., Vo, A. H., Mao, C., Clare, S. E., Khan, S. A., & Luo, Y. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103247 · Cited by 32 · see citing works
Kennedy, A. L., Adams, P. D., & Morton, J. P. (2011) · Small GTPases · doi:10.4161/sgtp.2.5.17367 · Cited by 31 · see citing works
Transgenic mouse models of breast cancer
Regua, A. T., Arrigo, A., Doheny, D. L., Wong, G. L., & Lo, H. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.027 · Cited by 30 · see citing works
Clark, P. E., Polosukhina, D., Love, H. D., Correa, H., Coffin, C. M., Perlman, E. J., deCaestecker, M. P., Moses, H. L., & Zent, R. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.08.006 · Cited by 30 · see citing works
Computational Methods for Characterizing Cancer Mutational Heterogeneity
Vandin, F. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00083 · Cited by 29 · see citing works
Functional KRAS mutations and a potential role for PI 3K/ AKT activation in Wilms tumors
Polosukhina, D., Love, H. D., Correa, H., Su, Z., Dahlman, K. B., Pao, W. J., Moses, H. L., Arteaga, C. L., Lovvorn, H. N., Zent, R., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12044 · Cited by 29 · see citing works
Important role of indels in somatic mutations of human cancer genes
Yang, H., Zhong, Y., Peng, C. Y., Chen, J., & Tian, D. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-128 · Cited by 28 · see citing works
Deciphering oncogenic drivers: from single genes to integrated pathways
Chen, J., Sun, M., & Shen, B. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbu039 · Cited by 27 · see citing works
Human germline and pan-cancer variomes and their distinct functional profiles
Pan, Y., Karagiannis, K., Zhang, H., Dingerdissen, H., Shamsaddini, A., Wan, Q., Simonyan, V. V., & Mazumder, R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku772 · Cited by 27 · see citing works
Paduch, R. (2014) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000024 · Cited by 26 · see citing works
Zhao, L., Zhang, M., Bai, L., Zhao, Y., Cai, Z., Yung, K. K. L., Dong, C., & Li, R. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17779-7 · Cited by 26 · see citing works
Li, Z., Shao, C., Liu, X., Lu, X., Jia, X., Zheng, X., Wang, S., Zhu, L., Li, K., Pang, Y., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz086 · Cited by 26 · see citing works
Pervasive Conditional Selection of Driver Mutations and Modular Epistasis Networks in Cancer
Iranzo, J., Gruenhagen, G. W., Calle-Espinosa, J., & Koonin, E. V. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111272 · Cited by 25 · see citing works
Percolation transition of cooperative mutational effects in colorectal tumorigenesis
Shin, D., Lee, J., Gong, J., & Cho, K. (2017) · Nature Communications · doi:10.1038/s41467-017-01171-6 · Cited by 26 · see citing works
Typing tumors using pathways selected by somatic evolution
Wang, S., Ma, J., Zhang, W., Shen, J. P., Huang, J. K.-L., Peng, J., & Ideker, T. E. (2018) · Nature Communications · doi:10.1038/s41467-018-06464-y · Cited by 23 · see citing works
Wang, L., Wu, Z., Xia, Y., Lü, X., Li, J., Fan, L., Qiao, C., Qiu, H. R., Xu, W., Xu, W., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.798 · Cited by 23 · see citing works
Identification of mutated driver pathways in cancer using a multi-objective optimization model
Zheng, C.-H., Wu, Y., Chong, Y., & Xia, J. (2016) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2016.03.002 · Cited by 23 · see citing works
Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers
Zhang, W., Edwards, A., Flemington, E. K., & Zhang, K. (2017) · Cancer Informatics · doi:10.1177/1176935117691267 · Cited by 20 · see citing works
Systematic Interpretation of Comutated Genes in Large-Scale Cancer Mutation Profiles
Gu, Y., Yang, D., Zou, J., Ma, W., Wu, R., Zhao, W., Zhang, Y., Xiao, H., Gong, X., Zhang, M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0022 · Cited by 20 · see citing works
Optimization of cell lines as tumour models by integrating multi-omics data
Zhao, N., Liu, Y., Wei, Y., Yan, Z., Zhang, Q., Wu, C., Chang, Z., & Xu, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw082 · Cited by 20 · see citing works
Selected technologies for measuring acquired genetic damage in humans
Shuga, J., Zeng, Y., Novak, R., Mathies, R. A., Hainaut, P. L., & Smith, M. T. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20630 · Cited by 19 · see citing works
Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma
Pyatnitskiy, M. A., Karpov, D. S., Poverennaya, E. V., Lisitsa, A., & Moshkovskii, S. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142819 · Cited by 19 · see citing works
Finding driver pathways in cancer: models and algorithms
Vandin, F., Upfal, E., & Raphael, B. J. (2012) · Algorithms for Molecular Biology · doi:10.1186/1748-7188-7-23 · Cited by 19 · see citing works
Zhang, B., Zhang, L., Yue, D., Li, C., Zhang, H., Ye, J., Gao, L., Zhao, X., Chen, C., Huo, Y., et al. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-19-664 · Cited by 19 · see citing works
Cancer: leaping the E‐cadherin hurdle
Chen, G. T., & Waterman, M. L. (2015) · The EMBO Journal · doi:10.15252/embj.201592757 · Cited by 18 · see citing works
Identification of driver modules in pan-cancer via coordinating coverage and exclusivity
Gao, B., Li, G., Liu, J., Li, Y., & Huang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.16433 · Cited by 18 · see citing works
The prognostic significance of a novel ferroptosis-related gene model in breast cancer
Lu, Y., Gong, Y., Li, W., Zhao, C., & Guo, F. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-479 · Cited by 17 · see citing works
Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials
Wilkins, J. F., Cannataro, V. L., Shuch, B., & Townsend, J. P. (2018) · Oncotarget · doi:10.18632/oncotarget.25155 · Cited by 17 · see citing works
Hušková, H., Ardin, M., Weninger, A., Vargová, K., Ghamry-Barrin, S., Villar, S., Olivier, M., Stopka, T., Herceg, Z., Hollstein, M., et al. (2017) · Oncogene · doi:10.1038/onc.2017.215 · Cited by 16 · see citing works
- Authors
- Yeang, C.-H., McCormick, F., & Levine, A.
- Affiliations
- Institute for Advanced Study (US)
- University of California, San Francisco (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2008-04-23
- Volume
- 22
- Issue
- 8
- Pages
- 2605-2622
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2126172213
- Cited by
- 251
- References
- 54
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 11 · 2023: 9 · 2022: 13 · 2021: 14 · 2020: 15 · 2019: 23 · 2018: 15 · 2017: 18 · 2016: 22 · 2015: 24 · 2014: 23 · 2013: 9 · 2012: 11
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- somatic mutations, COSMIC, oncogenes, tumor suppressor, co-occurring mutations, pathway signatures, Ras signaling, Wnt signaling
- MeSH terms
- Cell Cycle, Humans, Models, Genetic, Mutation, Neoplasms, Oncogenes, Organ Specificity, Stress, Physiological, Signal Transduction, Genes, Tumor Suppressor, Databases, Genetic, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
